川金諾(300505.SZ)擬對廣西川金諾增資2.5億元 以實施募投項目
格隆匯 1 月 8日丨川金諾(300505.SZ)公佈,公司已於2021年1月8日召開第四屆董事會第四次會議、第四屆監事會第四次會議,審議通過了《關於使用募集資金向控股子公司增資以實施募投項目的議案》。為保障公司控股子公司廣西川金諾化工有限公司(“廣西川金諾”)為主體的“濕法磷酸淨化及精細磷酸鹽項目”的順利推進和實施,公司擬對廣西川金諾增資2.5億元(其中使用向不特定對象發行可轉換債券募集資金約2.48億元)用於募投項目的實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.